Klivira
Request demo

Streamlining Medicaid Briumvi Prior Authorization Workflows

Successfully managing Medicaid Briumvi prior authorization is critical for timely patient access to this essential therapy. Klivira's platform automates the submission and tracking process, adapting to the nuanced requirements of state Medicaid programs and their managed care organizations.

Briumvi (ublituximab) is an anti-CD20 monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis (RMS). As a high-cost specialty medication, Briumvi is a frequent target for prior authorization across all payer types, including Medicaid. The complexity of Medicaid's state-by-state administration, coupled with the prevalence of managed care organizations (MCOs), introduces significant variability into the PA process for drugs like Briumvi.

Medicaid Delivery Models and Briumvi PA Impact

Medicaid operates through two primary delivery models: Fee-for-Service (FFS) and Medicaid Managed Care. For Briumvi prior authorizations, this distinction is crucial. FFS programs typically route PA requests directly to the state Medicaid agency's fiscal agent, while managed care plans, which administer benefits for the majority of enrollees, direct PA workflows to the responsible MCO. MCOs, such as Centene subsidiaries, Molina, or UHC Community Plan, have their own specific operational processes, although state Medicaid agency rules establish the floor for medical necessity criteria.

Common Prior Authorization Requirements for Specialty Drugs in Medicaid

  • Diagnosis confirmation and supporting clinical documentation (e.g., MRI scans, EDSS scores for MS).
  • Documentation of prior therapy failures or contraindications to preferred alternatives (step therapy).
  • Patient-specific criteria, such as age, weight, or disease severity.
  • Quantity limits or duration of therapy reviews.
  • Attestation of administration in an appropriate setting (e.g., infusion center).

Navigating Briumvi PA Submission Channels for Medicaid

The channel for submitting a Medicaid Briumvi prior authorization varies significantly by state and delivery model. FFS submissions typically utilize a state Medicaid portal. For managed care members, submissions are routed through the specific MCO's provider portal. Additionally, the X12 278 transaction standard is supported by some payers for electronic prior authorization (ePA) routing, offering a more integrated submission pathway where available. Klivira's platform intelligently identifies the correct channel and payer for each Briumvi PA request.

CMS-0057-F and Medicaid Managed Care Prior Authorization

Medicaid managed care organizations (MCOs) are designated as impacted payers under the CMS-0057-F Interoperability and Prior Authorization final rule. This rule mandates specific PA decision timeframes—72 hours for standard requests and 24 hours for expedited requests—and requires the implementation of FHIR-based Prior Authorization APIs on a phased timeline. While traditional FFS Medicaid is less directly impacted by the API requirements, these provisions aim to enhance efficiency and transparency in PA processes, directly affecting specialty drug approvals like Briumvi within MCOs.

Klivira's Approach to Medicaid Briumvi Prior Authorization

Klivira streamlines Medicaid Briumvi prior authorization by intelligently routing requests based on the specific delivery model (FFS vs. managed care) and responsible MCO. Our system accesses state Medicaid agency policy libraries to ensure compliance with medical necessity criteria, which serve as the baseline for all MCOs. For dual-eligible Medicare and Medicaid members (D-SNPs), Klivira coordinates benefits to ensure accurate submission and reduce administrative burden. This targeted approach helps mitigate common delays and denials associated with the varied Medicaid landscape.

Frequently asked questions

How does Medicaid's FFS vs. Managed Care model affect Briumvi PA submissions?

In Fee-for-Service (FFS) Medicaid, Briumvi PA requests are submitted directly to the state Medicaid agency's fiscal agent, often via a state portal. For Medicaid Managed Care, the PA is submitted to the specific Managed Care Organization (MCO) responsible for the member's benefits, typically through their dedicated provider portal. Klivira's system identifies the correct pathway automatically.

Are there specific turnaround times for Medicaid Briumvi prior authorizations?

Yes, for Medicaid Managed Care Organizations (MCOs), the CMS-0057-F rule mandates specific decision timeframes: 72 hours for standard prior authorization requests and 24 hours for expedited requests. These timeframes apply to specialty drugs like Briumvi, ensuring a more predictable process for providers.

What documentation is typically required for Briumvi PA under Medicaid?

Common documentation includes clinical notes confirming the diagnosis of relapsing multiple sclerosis, supporting imaging (e.g., MRI), documentation of prior therapies and their outcomes, and any other criteria specified in the state's Medicaid medical necessity policies or the MCO's clinical guidelines. Klivira helps aggregate and submit this information efficiently.

Can Medicaid MCOs impose stricter Briumvi PA criteria than the state Medicaid program?

No, Medicaid Managed Care Organizations (MCOs) cannot impose more restrictive medical necessity criteria than those established by the state Medicaid agency. State Medicaid policies serve as the baseline, and MCOs must adhere to these minimum standards for prior authorization of medications like Briumvi.

How does Klivira help with state-specific Medicaid Briumvi PA requirements?

Klivira's platform is designed to navigate state-specific Medicaid requirements by identifying the responsible delivery model (FFS or MCO) and MCO for each member. It leverages access to state Medicaid policy libraries to ensure Briumvi PA submissions align with the most current medical necessity criteria, reducing the likelihood of denials due to non-compliance with local rules.

Related coverage

Other briumvi prior authorization by payer

Other briumvi prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo